Compare MCK & KKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCK | KKR |
|---|---|---|
| Founded | 1833 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.4B | 109.0B |
| IPO Year | N/A | 2010 |
| Metric | MCK | KKR |
|---|---|---|
| Price | $823.39 | $134.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 15 |
| Target Price | ★ $882.69 | $155.07 |
| AVG Volume (30 Days) | 848.8K | ★ 4.4M |
| Earning Date | 02-04-2026 | 02-03-2026 |
| Dividend Yield | 0.40% | ★ 0.54% |
| EPS Growth | ★ 66.19 | N/A |
| EPS | ★ 32.12 | 2.37 |
| Revenue | ★ $387,094,000,000.00 | $22,245,686,000.00 |
| Revenue This Year | $14.87 | N/A |
| Revenue Next Year | $8.32 | $31.86 |
| P/E Ratio | ★ $25.34 | $57.72 |
| Revenue Growth | ★ 17.23 | N/A |
| 52 Week Low | $558.13 | $86.15 |
| 52 Week High | $895.58 | $170.40 |
| Indicator | MCK | KKR |
|---|---|---|
| Relative Strength Index (RSI) | 48.87 | 61.14 |
| Support Level | $793.92 | $119.09 |
| Resistance Level | $826.00 | $144.84 |
| Average True Range (ATR) | 17.23 | 4.14 |
| MACD | -5.04 | 1.66 |
| Stochastic Oscillator | 31.66 | 63.99 |
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
KKR is one of the world's largest alternative asset managers, with $723.2 billion in total managed assets, including $585.0 billion in fee-earning AUM, at the end of September 2025. The company has two core segments: asset management (which includes private markets—private equity, credit, infrastructure, energy, and real estate—and public markets—primarily credit and hedge/investment fund platforms) and insurance (following the firm's initial investment in, and then ultimate purchase of, Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance).